AMGEN Symposium
Wednesday 11th August 5-6:30pm
Four Seasons Hotel, Sydney
Multiple pathways, singular vision: working with you to
improve patients' lives.
Amgen invites you to hear three eminent Australian speakers
that highlight our commitment to the treatment of cancer and
its complications.
Professor Steve Ackland (Chair)
Professor and Area Director of Clinical Cancer Research at
HNE Health, Newcastle, NSW.
Associate Professor Michael Green
Royal Melbourne and Western Hospitals, Melbourne, VIC.
“Managing chemotherapy induced neutropenia and the role of
the neutrophil cytokines Pegfilgrastim (Neulasta®) and
Filgrastim (Neupogen®)."
Associate Professor Lara Lipton
Ludwig Institute for Cancer Research & Royal Melbourne
Hospital & Western Hospital,WA.
"The use of biomarkers in enhancing effectiveness of
colorectal cancer treatment.”
Dr Paul de Souza
St George Private Hospital, Kogarah, NSW.
"The important role of RANK ligand in bone metastases."
The objectives of these lectures are for participants to
test their knowledge and understand:
- The use of Pegfilgtim and Filgrastim to reduce febrile Neutropenia,
- The clinical impact of neutropenia and febrile neutropenia on the delivery of chemotherapy at full dose and on time,
- The use of biomarkers in enhancing the effectiveness of treatment for colorectal cancer, and
- The role of RANK ligand in bone metastases.
